Congress Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-63,813
| Closed | -$3.34M | – | 346 |
|
|
2019
Q3 | $3.34M | Buy |
63,813
+3,353
| +6% | +$175K | 0.04% | 227 |
|
|
2019
Q2 | $2.92M | Sell |
60,460
-12,698
| -17% | -$613K | 0.04% | 245 |
|
|
2019
Q1 | $3.7M | Sell |
73,158
-1,715
| -2% | -$86.6K | 0.05% | 217 |
|
|
2018
Q4 | $4.44M | Sell |
74,873
-8,248
| -10% | -$489K | 0.07% | 166 |
|
|
2018
Q3 | $5.47M | Sell |
83,121
-4,861
| -6% | -$320K | 0.07% | 178 |
|
|
2018
Q2 | $4.44M | Buy |
87,982
+3,251
| +4% | +$164K | 0.06% | 194 |
|
|
2018
Q1 | $4.46M | Buy |
84,731
+23,168
| +38% | +$1.22M | 0.06% | 188 |
|
|
2017
Q4 | $2.86M | Buy |
61,563
+3,507
| +6% | +$163K | 0.04% | 227 |
|
|
2017
Q3 | $2.35M | Buy |
58,056
+5,976
| +11% | +$242K | 0.04% | 236 |
|
|
2017
Q2 | $1.77M | Buy |
52,080
+4,632
| +10% | +$157K | 0.03% | 177 |
|
|
2017
Q1 | $1.38M | Buy |
47,448
+30,824
| +185% | +$895K | 0.03% | 185 |
|
|
2016
Q4 | $546K | Buy |
16,624
+9,819
| +144% | +$322K | 0.01% | 200 |
|
|
2016
Q3 | $215K | Buy |
+6,805
| New | +$215K | ﹤0.01% | 244 |
|